Skip to main content

Xvivo Perfusion

XVIVO Perfusion AB is a Swedish medical technology company specialized in organ preservation, evaluation, and perfusion systems for organ transplantation procedures. The company develops perfusion machines, preservation solutions, and single-use disposable sets for lungs, hearts, and livers awaiting transplantation. Primary revenue streams consist of machine device sales, organ preservation solution consumables, single-use tubing kits, and clinical support services. XVIVO Perfusion serves transplant centers, university hospitals, organ procurement organizations, and thoracic surgery clinics globally. The enterprise commands a dominant global market position in warm perfusion technology and lung preservation systems for organ transplantation. XVIVO Perfusion AB is headquartered in Gothenburg, Sweden, and its common shares are listed on Nasdaq Stockholm.

17 of the funds FundTelligence covers report a position in Xvivo Perfusion.

Sector
Health Care
Country
Sweden
Funds holding it
17

Funds holding Xvivo Perfusion

Showing the 8 largest of 17 funds holding it.

Loading...